Zobrazeno 1 - 10
of 115
pro vyhledávání: '"Grandeury, A."'
Publikováno v:
Pharmaceutics, Vol 16, Iss 5, p 604 (2024)
We introduce an innovative theoretical framework tailored for the analysis of Pair Distribution Function (PDF) data derived from Small-Angle X-ray Scattering (SAXS) measurements of core-shell micelles. The new approach involves the exploitation of th
Externí odkaz:
https://doaj.org/article/e4fce98c2c5b4a5784bf212d44dd4e71
Autor:
De Caro, Liberato, Giudice, Alessandra Del, Morin, Mickael, Reinle-Schmitt, Mathilde, Grandeury, Arnaud, Gozzo, Fabia, Giannini, Cinzia
Publikováno v:
In Journal of Pharmaceutical Sciences January 2023 112(1):243-249
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
CHIMIA, Vol 76, Iss 11 (2022)
Externí odkaz:
https://doaj.org/article/04cd559bf24e4f6aaccdb4df9ff6c345
Publikováno v:
Journal of Innovation Management, Vol 9, Iss 4, Pp I-IX (2022)
Innovation activities in large organizations are typically conducted by teams. Previous research noted the positive correlation between innovation performance and the cultural diversity of teams, wherein people from different backgrounds approach pro
Externí odkaz:
https://doaj.org/article/8e73854b9dd04a78b33fd31b464f6a5f
Autor:
Bitterlich, A., Laabs, C., Krautstrunk, I., Dengler, M., Juhnke, M., Grandeury, A., Bunjes, H., Kwade, A.
Publikováno v:
In European Journal of Pharmaceutics and Biopharmaceutics May 2015 92:171-179
Autor:
Liberato De Caro, Alessandra Del Giudice, Mickael Morin, Mathilde Reinle-Schmitt, Arnaud Grandeury, Fabia Gozzo, Cinzia Giannini
Publikováno v:
Journal of pharmaceutical sciences.
We developed a simple two-dimensional/two-components theoretical model that describes the structure and functionality of a VitE-TPGS system of micelles assuming a hydrophobic inner core and an outer hydrated hydrophilic shell. We then conceptually ap
Publikováno v:
In Annales Pharmaceutiques Francaises 2010 68(4):212-217
Autor:
S. Dhuria, Felix Huth, Shu Yang, Mohamed Elmeliegy, C. Germa, Marc Laisney, Arnaud Grandeury, Martin Mueller-Zsigmondy, Yasong Lu, Tanay S. Samant, Michelle Miller, Kenichi Umehara
Publikováno v:
Clinical Pharmacology and Therapeutics
Ribociclib (KISQALI), a cyclin-dependent kinase 4/6 inhibitor approved for the first-line treatment of HR+/HER2- advanced breast cancer with an aromatase inhibitor, is administered with no restrictions on concomitant gastric pH-elevating agents or fo
Publikováno v:
Polymorphism in the Pharmaceutical Industry
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1c0eb6aadbe805d8c37fb65e7454ef4d
https://doi.org/10.1002/9783527697847.ch2
https://doi.org/10.1002/9783527697847.ch2